Search or

𝛼SK

ENTITY

BRIM Biotechnology (6885 TT)

Health Care • Taiwan

BRIM Biotechnology, Inc. operates biotechnology businesses. The Company develops new drugs for oncology and infectious disease. BRIM Biotechnology conducts business throughout Taiwan.

more

Refresh

Exchange Announcement • 10 Nov 2025 18:27

Announcement Of Release Of The President From Non-Competition Restrictions For The Board Meeting

Exchange Announcement • 10 Nov 2025 18:26

Announce The Third Quarter 2025 Consolidated Financial Report Has Been Approved By The Board Of Directors

Exchange Announcement • 02 Nov 2025 11:05

Announcement For The Date Of The Board Of Directors Meeting For The Third Quarter 2025 Consolidated Financial Report Is 2025/11/10.

Exchange Announcement • 15 Oct 2025 19:06

Taiwan Mohw Approved The Protocol Amendment For The Phase Ii Clinical Trial Of Brm421 In Patients With Dry Eye Disease.

Exchange Announcement • 30 Sep 2025 18:50

The Company Submitted The Phase Iii Clinical Study Protocol Of Brm421 In Patients With Dry Eye Disease To U.S. Fda

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.60.3

x